Long-Term Effectiveness of BNT162b2 Pfizer-BioNTech mRNA-Based Vaccine on B Cell Compartment: Efficient Recall of SARS-CoV-2-Specific Memory B Cells

At present, there is a lack of clinical evidence about the impact and long-term durability of the immune response induced by the third dose of mRNA vaccines. In this study, we followed up the B cell compartment behavior in a cohort of immunocompetent individuals three and six months after the third...

Descripción completa

Detalles Bibliográficos
Autores principales: Busà, Rosalia, Miele, Monica, Sorrentino, Maria Concetta, Amico, Giandomenico, Timoneri, Francesca, Miceli, Vitale, Di Bella, Mariangela, Russelli, Giovanna, Gallo, Alessia, Zito, Giovanni, Iannolo, Gioacchin, Conaldi, Pier Giulio, Bulati, Matteo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738945/
https://www.ncbi.nlm.nih.gov/pubmed/36499373
http://dx.doi.org/10.3390/ijms232315046

Ejemplares similares

Ejemplares similares